OR WAIT null SECS
April 06, 2016
Inflectra is the second biosimilar to hit the market in the United States.
The companies announced that they have mutually decided to terminate the planned merger after the US Department of Treasury and the IRS issue temporary and proposed regulations on tax inversion.
April 05, 2016
Jack Lew, Obama’s secretary of the treasury, announced on April 4, 2016, that the US Department of the Treasury and the Internal Revenue Service (IRS) is issuing temporary and proposed regulations to limit the “benefits of and limit the number of corporate tax inversions.” The government bodies also plan to address earnings stripping in these inversions, so it will examine past inversion deals that have already been completed.
March 29, 2016
Industry is joining with academia and global health leaders to examine new approaches to biotech manufacturing.
March 24, 2016
The taskforce will work to identify opportunities to advance therapy manufacturing and the supply chain in the UK.
March 21, 2016
The studies, conducted across eight countries with nearly 600 inflammatory bowel disease (IBD) patients, further support claims by Celltrion that Remsima is highly similar its reference product.
March 18, 2016
During a clinical trial of 48 participants, 100% of those that received the TV003 vaccine were protected from infection.
March 17, 2016
Sir Andrew Witty, CEO of GlaxoSmithKline, has said that he plans to retire from the company in March 2017, after nearly ten 10 years in the position.
March 16, 2016
With a new name formed from the legacy company names, Alcami offers development services, analytical testing, and API and finished drug development and manufacturing.
March 10, 2016
The committee suggests there may be a connection between the Zika virus and other neurological disorders in some affected areas.